These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 61862)

  • 1. Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man.
    Jähnchen E; Meinertz T; Gilfrich HJ; Groth U
    Eur J Clin Pharmacol; 1976 Sep; 10(5):349-56. PubMed ID: 61862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings: Pharmacokinetic analysis of the dicumarol-tolbutamide interaction in man.
    Jähnchen E; Gilfrich HJ; Groth U; Meinertz T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R88. PubMed ID: 49859
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the pharmacokinetic interaction between ticagrelor and tolbutamide, a cytochrome P450 2C9 substrate, in healthy volunteers.
    Teng R; Mitchell P; Butler K
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):305-12. PubMed ID: 23380426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):321-6. PubMed ID: 7106168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of dicoumarol bioavailability by concomitant food intake.
    Melander A; Wåhlin E
    Eur J Clin Pharmacol; 1978 Dec; 14(6):441-4. PubMed ID: 83942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L; Kristensen M; Hansen M; Siersbaek-Nielsen K
    Acta Med Scand; 1976; 199(6):513-5. PubMed ID: 59517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-protein binding: a method for studying the interactions of drugs with bishydroxycoumarin (dicoumarol) in dogs.
    Welch RM
    Ann N Y Acad Sci; 1973 Nov; 226():259-66. PubMed ID: 4129139
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus.
    Appel S; Rüfenacht T; Kalafsky G; Tetzloff W; Kallay Z; Hitzenberger G; Kutz K
    Am J Cardiol; 1995 Jul; 76(2):29A-32A. PubMed ID: 7604792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of coumarin anticoagulants XV: relationship between pharmacokinetics of dicumarol and warfarin in rats.
    Yacobi A; Lai CM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1995-98. PubMed ID: 54415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of coumarin anticoagulants XXXVII: Simultaneous in vivo displacement of dicumarol from serum protein and tissue binding sites by tolbutamide in rats.
    Lai CM; Levy G
    J Pharm Sci; 1978 Oct; 67(10):1492-3. PubMed ID: 81299
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of drug-drug interactions in sheep: tolbutamide and sulfadimethoxine.
    Thiessen JJ; Rowland M
    J Pharm Sci; 1977 Aug; 66(8):1063-70. PubMed ID: 894490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of phenylbutazone and tolbutamide in man.
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of inhibition of tolbutamide hydroxylation by cimetidine in man.
    Stockley C; Keal J; Rolan P; Bochner F; Somogyi A
    Eur J Clin Pharmacol; 1986; 31(2):235-7. PubMed ID: 3803421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tricyclic antidepressants on drug metabolism.
    Pond SM; Graham GG; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1975 Aug; 18(2):191-9. PubMed ID: 50160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between tolbutamide and ketoconazole in healthy subjects.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Br J Clin Pharmacol; 1994 Feb; 37(2):205-7. PubMed ID: 8186066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
    Madari H; Panda D; Wilson L; Jacobs RS
    Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1982 Jun; 10(3):297-316. PubMed ID: 7175701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.
    Zilly W; Breimer DD; Richter E
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):219-27. PubMed ID: 1233266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tolbutamide treatment on the pharmacokinetics of intravenously administered sulphamethoxazole in rabbits.
    Ghosh SS; Garg SK; Mathur VS
    Pharmacology; 1987; 35(1):61-4. PubMed ID: 3628462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.